A particular challenge is to potentially interfere with adult brain plasticity processes to improve cognitive performance by using Gal-3 as an endogenous modulator of neuroinflammation/neurodegeneration and ligand for TLR and TREM2 as key receptors in microglial activation and brain trauma. The gene discussed is TREM2; the disease is brain injury.